This document summarizes data from the Pan Asian Resuscitation Outcomes Study (PAROS) clinical research network on out-of-hospital cardiac arrests across several Asian countries from 2009-2012. Key findings include: total cases reported were over 66,000 with wide variation in bystander CPR rates between countries (10.5-42.4%); survival rates for witnessed ventricular fibrillation arrests ranged from no reported survivors to 31.2%; overall survival to hospital discharge was 1.3-8.9% with good neurological function less than 5% for all countries. Baseline characteristics like age, gender, location of arrest varied significantly between participating countries in the PAROS study.
Artificial Intelligence, System Analysis and Simulation Modeling in Precise Prediction of 5-Year Survival of Esophageal Cancer Patients after Complete Esophagogastrectomies
Impact of Emergency Presentation on Colon Cancer Surgical Stay and OutcomesRamzi Amri
Abstract, Academic Surgical Congress 2014:
Introduction:
Urgent presentation is an unequivocal poor prognostic factor in patients with colon cancer. This abstract assesses the magnitude of the negative effects associated with an emergency presentation in patients with surgically treated colon cancer.
Methods:
All patients diagnosed with colon cancer who underwent surgery at Massachusetts General Hospital from 2004 through 2011 were included. Emergency presentation is defined as presentation or referral to our center requiring immediate surgical treatment following diagnosis of colon cancer that was subsequently confirmed through pathology. We compared dichotomous outcomes among emergency and elective patients using the Chi-square test and a relative risk (RR) calculation, while linear regression was used for continuous outcomes, the unstandardized B regression coefficient was used as a point estimate of differences in time-related outcomes.
Results:
We included 1071 patients, of whom 97 were emergency admissions, 79 of which came from our Emergency department. Emergency patients required longer surgeries (median duration 141 vs. 124 minutes, P=0.026), had a median of three day longer length of stay (P<0.001),><0.001)><0.001),><0.001) rates.
Conclusions:
Emergency presentation is predictive for more advanced disease and far worse outcomes. Longer surgeries, stays, and higher readmission rates means these presentations will also lead to significantly higher healthcare costs. This is another strong argument for preventive care and screening colonoscopy.
April28 ilo safe day in turkey 2015 04 28Jukka Takala
J. Takala's presentation on April 28, 2015, in an ILO World Day for Safety and Health at Work, SafeDay Conference in Ankara, Turkey. "Safe Work - Healthy Work - For Life"
Survival of Esophageal Cancer Patients was Significantly Superior in Comparison with Cardioesophageal Cancer Patients after Surgery
Kshivets Oleg Surgery Department, Roshal Hospital, Moscow, Russia
OBJECTIVE: This study aimed to determine localization influence of tumor for 5-year survival (5YS) of esophageal (EC) or cardioesophageal (CC) cancer patients (ECP, CEP) after complete en block (R0) esophagogastrectomies (EG) through left/right thoracoabdominal incision.
METHODS: We analyzed data of 543 consecutive patients (age=56.4±8.8 years; tumor size=6±3.5 cm) radically operated (R0) and monitored in 1975-2019 (m=405, f=138; ECP=259, CEP=284; esophagogastrectomies (EG) Garlock=280, EG Lewis=263, combined EG with resection of pancreas, liver, diaphragm, aorta, VCS, colon transversum, lung, trachea, pericardium, splenectomy=151; adenocarcinoma=308, squamous=225, mix=10; T1=126, T2=114, T3=178, T4=125; N0=275, N1=69, N2=199; G1=157, G2=139, G3=247; early EC=107, invasive=436; only surgery=420, adjuvant chemoimmunoradiotherapy-AT=123: 5-FU+thymalin/taktivin+radiotherapy 45-50Gy). Multivariate Cox modeling, clustering, SEPATH, Monte Carlo, bootstrap and neural networks computing were used to determine any significant dependence.
RESULTS: Overall life span (LS) was 1892.4±2241 days and cumulative 5-year survival (5YS) reached 51.9%, 10 years – 45.7%, 20 years – 33.5%. 183 ECP lived more than 5 years (LS=4311±2419.7 days), 98 ECP – more than 10 years (LS=5903.4±2299.4 days). 224 died because of EC/CC (LS=629.2±320.1 days). 5YS of ECP (67.3%, LS=2605±2628.9 days) was significantly superior in comparison with CEP (36.4%, LS=1242.6±1558.5 days) (P=0.00000 by log-rank test). AT significantly improved 5YS (68.2% vs. 48.5%) (P=0.00033 by log-rank test). Cox modeling displayed that 5YS of ECP/CEP significantly depended on: phase transition (PT) N0—N12 in terms of synergetics, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), T, G, histology, age, AT, localization, blood cells, prothrombin index, coagulation time, residual nitrogen, blood group, Rh, glucose, protein (P=0.000-0.008). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and healthy cells/CC (rank=1), PT early-invasive EC (rank=2), PT N0—N12 (rank=3), erythrocytes/CC (4), thrombocytes/CC (5), stick neutrophils/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), eosinophils/CC (9), leucocytes/CC (10), monocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
A speech given in Yodak Hospital, the 6th International Symposium of Cardiac Thorascopic Surgery, 10/25/2014; a report of endoscopic cardiac surgery in Taiwan
Repartizare burse FEAA
| Print |
Conform Regulamentului de acordare a burselor şi altor forme de sprijin material pentru studenţi aprobat în şedinţa Senatului Universităţii din Craiova din data de 25 martie 2021, fondul pentru burse repartizat facultăţii noastre proporţional cu nr. de studenţi bugetari pentru fiecare ciclu de studii în parte, aferent semestrului I al anului universitar 2022/2023, a fost utilizat astfel:
• Bursele de performanţă s-au acordat în nr. de 2 la ciclul LICENŢĂ şi 2 la ciclul MASTER, conform Hotărârii Consiliului de Administraţie al Universitătii din Craiova, din data de 2.11.2022 (bursa de performanţă s-a acordat la începutul anului universitar pe durata întregului an).
• Din fondul de burse repartizat la ciclul LICENŢĂ, 30% a fost alocat pentru categoria de burse sociale.
• Din fondul de burse repartizat la ciclul MASTER, 30% a fost alocat pentru categoria de burse sociale.
• Bursele de merit la ciclul LICENŢĂ s-au acordat pentru toţi studenţii cu mediile cuprinse între 9,00 - 10, potrivit Regulamentului.
• Fondul pentru bursele de merit repartizat facultăţii noastre la ciclul MASTER s-a distribuit proporţional cu nr. de studenţi bugetari pentru fiecare an şi program de studii.
• Fondul de burse de merit rămas neconsumat la ciclul de licenţă a fost repartizat la master
• Fondul de burse de merit suplimentar repartizat FEAA a fost distribuit la Master, pe domenii, proporţional cu nr. studenţilor care deşi îndeplinesc media de bursă, nu au beneficiat iniţial din cauza fondurilor insuficiente.
Criteriile de departajare pentru acordarea burselor de merit în caz de egalitate de medii
Pt anul 1 licenţă şi master
Primul criteriu: punctele credit aferente mediei obtinute in anul respectiv;
Al doilea criteriu: media de admitere;
Al treilea criteriu: criteriile de departajare de la admitere.
Pentru anii 2,3 licenţă si 2 master
Primul criteriu: -punctele credit aferente mediei obtinute in anul respectiv;
Al doilea criteriu: totalul punctelor credit realizate;
Al treilea criteriu: media anului/anilor anteriori;
Al patrulea criteriu : media de la admitere ;
Al cincilea criteriu: criteriile de departajare de la admitere.
Eventualele contestaţii se pot depune pe mail, respectând specializările la care studenţii/masteranzii sunt înmatriculaţi, până la data de 9.11.2022 orele 12.00•
Pentru Craiova
Descarcă Lista nominală cu studenţii potenţial bursieri
Pentru Drobeta Tr, Severin
Descarcă Lista nominală cu studenţii potenţial bursieri
In this downloadable slideset, Joseph J. Eron, Jr., MD, reviews the evidence behind the latest antiretroviral guidelines and offers a glimpse at potential future agents and strategies currently under investigation.
Format: Microsoft PowerPoint (.ppt)
File size: 2.06 MB
Date posted: 6/1/2016
Artificial Intelligence, System Analysis and Simulation Modeling in Precise Prediction of 5-Year Survival of Esophageal Cancer Patients after Complete Esophagogastrectomies
Impact of Emergency Presentation on Colon Cancer Surgical Stay and OutcomesRamzi Amri
Abstract, Academic Surgical Congress 2014:
Introduction:
Urgent presentation is an unequivocal poor prognostic factor in patients with colon cancer. This abstract assesses the magnitude of the negative effects associated with an emergency presentation in patients with surgically treated colon cancer.
Methods:
All patients diagnosed with colon cancer who underwent surgery at Massachusetts General Hospital from 2004 through 2011 were included. Emergency presentation is defined as presentation or referral to our center requiring immediate surgical treatment following diagnosis of colon cancer that was subsequently confirmed through pathology. We compared dichotomous outcomes among emergency and elective patients using the Chi-square test and a relative risk (RR) calculation, while linear regression was used for continuous outcomes, the unstandardized B regression coefficient was used as a point estimate of differences in time-related outcomes.
Results:
We included 1071 patients, of whom 97 were emergency admissions, 79 of which came from our Emergency department. Emergency patients required longer surgeries (median duration 141 vs. 124 minutes, P=0.026), had a median of three day longer length of stay (P<0.001),><0.001)><0.001),><0.001) rates.
Conclusions:
Emergency presentation is predictive for more advanced disease and far worse outcomes. Longer surgeries, stays, and higher readmission rates means these presentations will also lead to significantly higher healthcare costs. This is another strong argument for preventive care and screening colonoscopy.
April28 ilo safe day in turkey 2015 04 28Jukka Takala
J. Takala's presentation on April 28, 2015, in an ILO World Day for Safety and Health at Work, SafeDay Conference in Ankara, Turkey. "Safe Work - Healthy Work - For Life"
Survival of Esophageal Cancer Patients was Significantly Superior in Comparison with Cardioesophageal Cancer Patients after Surgery
Kshivets Oleg Surgery Department, Roshal Hospital, Moscow, Russia
OBJECTIVE: This study aimed to determine localization influence of tumor for 5-year survival (5YS) of esophageal (EC) or cardioesophageal (CC) cancer patients (ECP, CEP) after complete en block (R0) esophagogastrectomies (EG) through left/right thoracoabdominal incision.
METHODS: We analyzed data of 543 consecutive patients (age=56.4±8.8 years; tumor size=6±3.5 cm) radically operated (R0) and monitored in 1975-2019 (m=405, f=138; ECP=259, CEP=284; esophagogastrectomies (EG) Garlock=280, EG Lewis=263, combined EG with resection of pancreas, liver, diaphragm, aorta, VCS, colon transversum, lung, trachea, pericardium, splenectomy=151; adenocarcinoma=308, squamous=225, mix=10; T1=126, T2=114, T3=178, T4=125; N0=275, N1=69, N2=199; G1=157, G2=139, G3=247; early EC=107, invasive=436; only surgery=420, adjuvant chemoimmunoradiotherapy-AT=123: 5-FU+thymalin/taktivin+radiotherapy 45-50Gy). Multivariate Cox modeling, clustering, SEPATH, Monte Carlo, bootstrap and neural networks computing were used to determine any significant dependence.
RESULTS: Overall life span (LS) was 1892.4±2241 days and cumulative 5-year survival (5YS) reached 51.9%, 10 years – 45.7%, 20 years – 33.5%. 183 ECP lived more than 5 years (LS=4311±2419.7 days), 98 ECP – more than 10 years (LS=5903.4±2299.4 days). 224 died because of EC/CC (LS=629.2±320.1 days). 5YS of ECP (67.3%, LS=2605±2628.9 days) was significantly superior in comparison with CEP (36.4%, LS=1242.6±1558.5 days) (P=0.00000 by log-rank test). AT significantly improved 5YS (68.2% vs. 48.5%) (P=0.00033 by log-rank test). Cox modeling displayed that 5YS of ECP/CEP significantly depended on: phase transition (PT) N0—N12 in terms of synergetics, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), T, G, histology, age, AT, localization, blood cells, prothrombin index, coagulation time, residual nitrogen, blood group, Rh, glucose, protein (P=0.000-0.008). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and healthy cells/CC (rank=1), PT early-invasive EC (rank=2), PT N0—N12 (rank=3), erythrocytes/CC (4), thrombocytes/CC (5), stick neutrophils/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), eosinophils/CC (9), leucocytes/CC (10), monocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
A speech given in Yodak Hospital, the 6th International Symposium of Cardiac Thorascopic Surgery, 10/25/2014; a report of endoscopic cardiac surgery in Taiwan
Repartizare burse FEAA
| Print |
Conform Regulamentului de acordare a burselor şi altor forme de sprijin material pentru studenţi aprobat în şedinţa Senatului Universităţii din Craiova din data de 25 martie 2021, fondul pentru burse repartizat facultăţii noastre proporţional cu nr. de studenţi bugetari pentru fiecare ciclu de studii în parte, aferent semestrului I al anului universitar 2022/2023, a fost utilizat astfel:
• Bursele de performanţă s-au acordat în nr. de 2 la ciclul LICENŢĂ şi 2 la ciclul MASTER, conform Hotărârii Consiliului de Administraţie al Universitătii din Craiova, din data de 2.11.2022 (bursa de performanţă s-a acordat la începutul anului universitar pe durata întregului an).
• Din fondul de burse repartizat la ciclul LICENŢĂ, 30% a fost alocat pentru categoria de burse sociale.
• Din fondul de burse repartizat la ciclul MASTER, 30% a fost alocat pentru categoria de burse sociale.
• Bursele de merit la ciclul LICENŢĂ s-au acordat pentru toţi studenţii cu mediile cuprinse între 9,00 - 10, potrivit Regulamentului.
• Fondul pentru bursele de merit repartizat facultăţii noastre la ciclul MASTER s-a distribuit proporţional cu nr. de studenţi bugetari pentru fiecare an şi program de studii.
• Fondul de burse de merit rămas neconsumat la ciclul de licenţă a fost repartizat la master
• Fondul de burse de merit suplimentar repartizat FEAA a fost distribuit la Master, pe domenii, proporţional cu nr. studenţilor care deşi îndeplinesc media de bursă, nu au beneficiat iniţial din cauza fondurilor insuficiente.
Criteriile de departajare pentru acordarea burselor de merit în caz de egalitate de medii
Pt anul 1 licenţă şi master
Primul criteriu: punctele credit aferente mediei obtinute in anul respectiv;
Al doilea criteriu: media de admitere;
Al treilea criteriu: criteriile de departajare de la admitere.
Pentru anii 2,3 licenţă si 2 master
Primul criteriu: -punctele credit aferente mediei obtinute in anul respectiv;
Al doilea criteriu: totalul punctelor credit realizate;
Al treilea criteriu: media anului/anilor anteriori;
Al patrulea criteriu : media de la admitere ;
Al cincilea criteriu: criteriile de departajare de la admitere.
Eventualele contestaţii se pot depune pe mail, respectând specializările la care studenţii/masteranzii sunt înmatriculaţi, până la data de 9.11.2022 orele 12.00•
Pentru Craiova
Descarcă Lista nominală cu studenţii potenţial bursieri
Pentru Drobeta Tr, Severin
Descarcă Lista nominală cu studenţii potenţial bursieri
In this downloadable slideset, Joseph J. Eron, Jr., MD, reviews the evidence behind the latest antiretroviral guidelines and offers a glimpse at potential future agents and strategies currently under investigation.
Format: Microsoft PowerPoint (.ppt)
File size: 2.06 MB
Date posted: 6/1/2016
Benjamin Leong - Dispatch assisted CPR in SingaporeRahul Goswami
Dr Benjamin Leong gives a comprehensive account of challenges and triumphs in the Singapore EMS - specifically the intervention of dispatcher CPR.
Find out more at singem.blogspot.sg
John Tobin was the keynote speaker at the EMS track for ASM 2014 and gives an account of where he works and the efforts they have made to pre-hospital deaths in his EMS.
Find out more at singem.blogspot.sg
SEMS 2014: Augustine Tee - Inpatient Medical Emergency TeamsRahul Goswami
The Critical Care track of the Society for Emergency Medicine in Singapore Annual Scientific Meeting 2014.
For more information and conference videos, go to singem.blogspot.sg
SEMS 2014: Dan Davis - Using technology in resusRahul Goswami
The Critical Care track of the Society for Emergency Medicine in Singapore Annual Scientific Meeting 2014.
For more information and conference videos, go to singem.blogspot.sg
SEMS 2014: Brendan Smith - Inotropy in resusRahul Goswami
The Critical Care track of the Society for Emergency Medicine in Singapore Annual Scientific Meeting 2014.
For more information and conference videos, go to singem.blogspot.sg
SEMS 2014: Ang Shiang Hu - Life threatening asthma Rahul Goswami
The Critical Care track of the Society for Emergency Medicine in Singapore Annual Scientific Meeting 2014.
For more information and conference videos, go to singem.blogspot.sg
Ilo Ilo... not the movie. DMAT Haiyan 2013.Rahul Goswami
Pictorial lecture on the services, learning points and experiences of the CGH/Mercy Relief mission in 2013 for Typhoon Haiyan to Ilo Ilo province, Panay, Philippines.
Video is here:http://youtu.be/dnKHTC5bvrI
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Evaluation of antidepressant activity of clitoris ternatea in animals
Marcus Ong - PAROS outcomes
1. A/Prof Marcus Ong Eng Hock
Senior Consultant, Clinician Scientist and Director of Research
Department of Emergency Medicine, Singapore General Hospital
Associate Director, Health Services and Systems Research
Duke-NUS Graduate Medical School, Singapore
The Pan Asian Resuscitation
Outcomes Study (PAROS)
2. Top 10 Causes of death by Country
Korea Singapore Taiwan Japan Thailand Malaysia Turkey UAE
1 Cancer Cancer Cancer Cancer Cerebrovasc
ular disease
Ischemic
heart
disease
Ischemic
heart
disease
Ischemic
heart
disease
2 Cerebrovas
cular
disease
Ischemic
Heart
disease
Heart
disease
Heart
disease
Malignant
neoplasm
Pneumonia Malignant
neoplasm
Road
traffic
accidents
3 Heart
disease
(IHD + etc)
Pneumonia Cerebrovasc
ular disease
Cerebrovasc
ular disease
Ischemic
heart
disease
Cerebrovas
cular
disease
Cerebrovas
cular
neoplasm
Malignant
neoplasm
4 Suicide Cerebrovasc
ular disease
Pneumonia Pneumonia Diabetes
mellitus
Septicaemi
a
Chronic
obstructive
pulmonary
disease
Cerebrova
scular
disease
5 Diabetes
Mellitus
Accident,
Poisoning &
Violence
Diabetes
Mellitus
Senility Chronic
obstructive
pulmonary
disease
Transport
accident
Lower
respiratory
infections
Hypertens
ive heart
disease
3. In 2010, Pan Asian Resuscitation Outcomes
Study (PAROS) Clinical Research Network
(CRN) was established in collaboration with
Japan, Singapore, South Korea, Malaysia,
Taiwan,Thailand, and UAE-Dubai.
This CRN aims to report the out-of-hospital
cardiac arrests (OHCA) events and provide a
better understanding of OHCA trends in Asia.
5. Methodology
Comparison of Out-of-Hospital Cardiac Arrest Cases
Database No. of
cases
Cardiac Arrest and Resuscitation Epidemiology
(CARE)
Oct 2001 – Oct 2004
2428
Pan Asian Resuscitation Outcomes Study (PAROS)
Apr 2010 – May 2012
3025
Total 5453
6. Characteristics
CARE
(n=2428)
PAROS
(n=3025)
Age Mean (SD) 60.6 (19.3) 63.5 (18.2)
Median (Range) 63.4 (50.4-74.4) 65.0 (53.0-77.0)
Gender (%) Male 1652 (63.0) 1988 (65.7)
Race (%)
Chinese 1687 (69.5) 2009 (66.4)
Malay 365 (15.0) 459 (15.2)
Indians 267 (11.0) 343 (11.3)
Others 108 (4.5) 214 (7.0)
Medical History (%)
No 282 (11.6) 383 (12.6)
Unknown 482 (19.9) 289 (9.4)
Heart Disease 788 (32.5) 1090 (35.9)
Diabetes 569 (23.4) 869 (28.7)
Hypertension 752 (31.0) 1430 (47.1)
Other 436 (18.0) 1058 (35.0)
Characteristics of Patients
7. Characteristics
CARE
(n=2428)
PAROS
(n=3025)
Location (%)
Home Residence 1703 (70.1) 2128 (70.0)
Healthcare Facility 103 (4.2) 110 (3.6)
Public/Commercial
Building
173 (7.1) 237 (7.8)
Industrial Place 43 (1.8) 63 (2.1)
Nursing Home 35 (1.4) 111 (3.7)
Place of Recreation 22 (0.9) 57 (1.9)
Street/Highway 108 (4.4) 155 (5.9)
Transport centre 36 (1.5) 37 (1.2)
In EMS/Private ambulance 67 (2.8) 69 (2.3)
Other 86 (3.5) 60 (2.0)
Characteristics of Patients
9. CARE
n=2428
PAROS
n=3025
P value
EMS time intervals in minutes, median (IQR)
For arrests that occurred before EMS
arrival:
Time of arrest – Time of call
6.4 (2.7– 13.0)
n=1546
5.8 (2.3-12.5)
n=2148
<0.20
For arrests that occur after EMS
arrival:
Time of call – Time of arrest
7.7 (2.8-18.0)
n= 627
6.33 (1.81-15.8)
n=720
0.04
FRP dispatch – FRP arrival at scene - 5.00 (4-7) -
Call to arrival at scene 9 (6.8-11.42) 7.96 (6.0-10.3) <0.001
Call to arrival at patient side 11.1 (9.0-14.0) 9.93 (7.8-12.6) <0.001
Arrival at patient side to leave scene 10.0 (7.0-12.6) 12.1 (10.0-14.7) <0.001
Leave scene to arrival at hospital 10.0 (7.0-14.2) 10.0 (7.0-13.9) 0.10
Call to ED 32.3 (27.4-38.1) 33.2 (28.4-38.5) 0.02
Resuscitation Factors
10. CARE
n=2428
PAROS
n=3025
Adjusted OR*
(95% CI)
Survival - All Arrests
Admitted 215 (9.0) 514 (17.0) 2.2 (1.8 - 2.6)
Discharged alive or Alive at
30 days
38 (1.6) 97 (3.3) 2.2 (1.5 - 3.3)
Post Arrest CPC 1/2 28 (1.2) 53 (1.8) 1.7 (1.1 - 2.8)
Survival - Utstein Style
Admitted 16/280 (5.7) 82/317 (26.8) 9.6 (3.9 – 23.3)
Discharged alive or Remain
alive at 30 days
7/280 (2.5) 35/317 (11.0) 9.6 (2.2 – 41.9)
Post Arrest CPC 1/2
6/280 (2.1) 22/317 (7.0) 6.0 (1.3 – 27.0)
*adjusted for age, gender, and history of heart disease
Survival for All Arrests and Utstein Arrests
13. Conclusion
• Additional 30+ lives are saved per year from OHCA compared to
10 years ago (20 survivors/year). More than half of them will go
back to a normal, independent, productive life.
• Greatest benefit seen from more public AEDs, hypothermia post
resuscitation, also possibly from more bystander CPR, faster
response time and ambulance care (defibrillation).
• Great potential for dispatcher-assisted CPR and AED to further
improve survival.
17. A prospective, international, multi-center cohort
study of OHCA across the Asia-Pacific.
Each participating country provided between 1.5
to 2.5 years of data from January 2009 to
December 2012.
A standardised taxonomy and case record form
are adopted to collect common variables.
Data were provided via two methods; using
electronic data capture system which is an online,
data registry or exported data from national
registry.
19. Country City
Service area
population
Population
density
(per KM2)
Data Source
No. of
ambulances
No. of
hospitals
Japan Aichi 7,434,996 1,439.46 EMS-centric 249 155
Japan Osaka 8,860,280 4,659.82 EMS-centric 285 272
Japan Tokyo 13,286,735 6,070.69 EMS-centric 218 276
Korea Seoul 10,249,679 16,941.6 EMS-centric 140 63
Malaysia Klang Valley 1,749,059 6,932.39 Hospital-centric 5 2
Malaysia Kota Bahru 491,237 1,247 Hospital-centric 30 2
Malaysia Penang 1,520,143 1,500 EMS-centric 7 1
Singapore Singapore 5,076,700 7,252.43 EMS-centric 46 7
Thailand Bangkok 2,521,240 19,014.36 Hospital-centric 16 2
Thailand Songkla 55,144 1,326.53 Hospital-centric 4 1
Taiwan Taipei 2,650,968 271.8 EMS-centric 50 22
UAE Dubai 2,003,170 474.79 EMS-centric 68 5
20. Total of 66,786 cases from January 2009 to
December 2012 were submitted to the
PAROS CRN.
Resuscitation attempted by EMS and
presumed cardiac etiology = 40,463 cases
Bystander CPR rates varied greatly for
different countries from 10.5% to 42.4%.
However < 1.0% of all these arrests received
bystander defibrillation.
21. For arrests that were witnessed andVF,
the survival rate to hospital discharge
varied from no reported survivors to
31.2%.
Overall survival to hospital discharge
varied from 1.3% to 8.9% and overall
survival with good neurological function
was <5% for all countries.
22. Characteristics
Japan
(n=51381)
Korea
(n=7990)
Malaysia
(n=389)
Singapore
(n=3025)
Thailand
(n=573)
Taiwan
(n=3023)
UAE
(n=405)
Age, mean (SD) 71.7 (18.4) 63.5 (19.0) 57.0 (17.0) 63.5 (18.2) 55.7 (22.1) 70.5 (18.6) 49.7 (18.3)
Median (IQR)
76.0
(63.0, 85.0)
66.5
(52.0, 78.0)
59.0
(47.0,70.0)
65.0
(53.0,77.0)
57.0
(40.0, 74.0)
75.0
(59.0, 85.0)
50.0
(38.0, 63.0)
Male (n, %) 29760 (57.9) 5243 (65.6) 276 (71.0) 1988 (65.7) 367 (64.0) 1936 (64.1) 335 (82.7)
Location Type (n, %)
Home residence 8409 (63.0) 5057 (64.9) 278 (71.5) 2128 (70.3) 354 (61.8) 2201 (73.1) 220 (54.3)
Healthcare facility 50 (0.4) 137 (1.8) 11 (2.8) 110 (3.6) 11 (1.9) NA 7 (1.7)
Public /commercial
building
964 (7.2) 449 (5.8) 44 (11.3) 237 (7.8) 30 (5.2) 70 (2.3) 52 (12.8)
Nursing home 1555 (11.7) 286 (3.7) 6 (1.5) 111 (3.7) 7 (1.2) 240 (8.0) NA
Street/highway 809 (6.1) 465 (6.0) 26 (6.7) 155 (5.1) 86 (15.0) 238 (7.9) 71 (17.5)
Industrial place NA 95 (1.2) 1 (0.3) 63 (2.1) 5 (0.9) 78 (2.6) 18 (4.4)
Transport center NA 101 (1.3) 3 (0.8) 37 (1.2) 2 (0.3) 4 (0.1) NA
Place of recreation NA 187 (2.4) 2 (0.5) 57 (1.9) 6 (1.0) 54 (1.8) 24 (5.9)
In EMS/private
ambulance
852 (6.4) 382 (4.9) 9 (2.3) 69 (2.3) 33 (5.8) NA NA
Other 700 (5.2) 629 (8.1) 9 (2.3) 58 (1.9) 39 (6.8) 125 (4.2) 13 (3.2)
25. Time Intervals (minutes)
Japan
(n=51381)
Korea
(n=7990)
Malaysia
(n=389)
Singapore
(n=3025)
Thailand
(n=573)
Taiwan
(n=3023)
UAE
(n=405)
Time of call to
Time arrival at
scene
(Response Time)
Mean(SD) 6.5 (3.1) 6.5 (4.3) 19.8 (12.3) 8.5 (3.9) 11.5 (6.0) 5.9 (3.1) 10.1 (5.0)
Median
(IQR)
6.0
(5.0, 8.0)
6.0
(5.0, 7.0)
17.4
(12.0, 24.2)
7.9
(5.9, 10.3)
11.3
(7.0, 15.3)
5.1
(4.1, 7.0)
9.0
(7.0, 12.0)
Time arrival at
scene to Time
leave scene
(Scene Time)
Mean(SD) 15.4 (7.3) 8.0 (9.0) 20.4 (15.3) 14.6 (4.9) 15.4 (13.3) 13.6 (9.9) 13.3 (7.1)
Median
(IQR)
14.0
(11.0, 19.0)
7.0
(5.0, 10.0)
15.8
(9.0, 27.5)
14.1
(11.6, 17.2)
10.0
(5.0, 24.3)
13.0
(10.0, 16.3)
12.0
(8.0, 17.0)
Time leave
location to Time
arrival at ED
(En-route Time)
Mean(SD) 7.3 (4.7) 7.4 (8.0) 11.1 (7.5) 10.8 (5.0) 14.2 (9.1) 4.6 (5.2) 12.2 (7.5)
Median
(IQR)
6.0
(4.0, 9.0)
6.0
(5.0, 9.0)
10.0
(6.0, 15.0)
10.0
(7.0, 13.9)
12.3
(8.0, 20.0)
4.0
(2.6, 5.1)
10.0
(7.0, 15.0)
Time of call to
Time arrival at
ED
Mean(SD) 33.3 (12.9) 21.9 (13.3) 42.8 (21.9) 33.9 (8.0) 41.5 (20.6) 24.1 (11.1) 35.5 (11.5)
Median
(IQR)
31.0
(26.0, 38.0)
21.0
(17.0, 25.0)
40.0
(28.0, 53.0)
33.2
(28.4, 38.5)
40.0
(25.0, 56.5)
23.0
(19.3, 27.0)
34.0
(28.0, 42.0)
26. Japan
(Tokyo,
Aichi,
Osaka)
Korea
(Seoul)
Malaysia
(Kuala Lumpur,
Kota Bahru,
Penang)
Singapore
Thailand
(Bangkok,
Songkla)
Taiwan
(Taipei)
UAE
(Dubai)
Overall
Total population coverage 29,582,011 10,249,679 3,760,439 5,076,700 2,576,384 2,650,968 2,003,170 55,899,351
Total number of all cases 51381 7990 389 3025 573 3023 405 66786
Total number of EMS cases 51381 7990 343 2960 299 3023 405 66401
Utstein (%)
Total 2199 669 5 322 11 122 46 3374
Incidence rate per 100 000 7 7 0 6 0 5 2 6
EMS ROSC 772 (35.1) 154 (23.0) Nil 36 (11.2) 1(9.1) 38 (31.1) 6 (13.0) 1007(29.8)
ED ROSC
Not
Available
294 (43.9) 1(20.0) 98 (30.4) 1(9.1) 62 (50.8) 9 (19.6) *465 (13.8)
Survived to admission
1 #374 (17.0) 290 (43.3) Nil 84 (26.1) 1(9.1) 29 (23.8) 10 (21.7) #788 (23.4)
Survived to discharged /
Alive at 30th day post
arrest
1
686 (31.2) 206 (30.8) Nil 37 (11.5) Nil 29 (23.8) 7 (15.2) 965 (28.6)
Post Arrest CPC 1/2
1
463 (21.1) 122 (18.2) NA 23 (7.1) NA 21 (17.2) 7 (15.2) 636 (18.9)
1
Not include transferred to another hospital
*Data not available from Japan
# Data not available from Tokyo and Aichi
27. Japan
(Tokyo,
Aichi,
Osaka)
Korea
(Seoul)
Malaysia
(Kuala Lumpur,
Kota Bahru,
Penang)
Singapore
Thailand
(Bangkok,
Songkla)
Taiwan
(Taipei)
UAE
(Dubai)
Overall
Total population coverage 29,582,011 10,249,679 3,760,439 5,076,700 2,576,384 2,650,968 2,003,170 55,899,351
Total number of all cases 51381 7990 389 3025 573 3023 405 66786
Total number of EMS cases 51381 7990 343 2960 299 3023 405 66401
All Resuscitation Attempted Arrests (%)
Total 51381 7537 217 2960 235 2998 405 65733
Incidence rate per 100 000 174 74 6 58 9 113 20 118
EMS ROSC 4397 (8.6) 366 (4.9) 9 (4.1) 149 (5.0) 41(17.4) 376 (12.5) 15 (3.7) 5353 (8.1)
ED ROSC
Not
Available
2652 (35.2) 17 (7.8) 773 (26.1) 66 (28.1) 896 (29.9) 24 (5.9) *4428 (6.7)
Survived to admission
1 #3644 (7.1) 1582 (21.0) 15 (6.9) 494 (16.7) 55 (23.4) 178 (5.9) 32 (7.9) #6000 (9.1)
Survived to discharged /
Alive at 30th day post
arrest
1
2677 (5.2) 706 (9.4) 5 (2.3) 88 (3.0) 7 (3.0) 176 (5.9) 13 (3.2) 3672 (5.6)
Post Arrest CPC 1/2
1
1436 (2.8) 235 (3.1) Not Available 49 (1.7) 4 ( 1.7) 90 (3.0) 12 (3.0) 1826 (2.8)
1
Not include transferred to another hospital
*Data not available from Japan
# Data not available from Tokyo and Aichi
28. * Excluded witnessed arrest by EMS and missing data #Data not available from Tokyo and Aichi
Sites
Mean
age (SD)
Male
*Bystander
CPR
performed
*Bystander
defibrillation
Witnessed
arrest by
Bystander
1st arrest
rhythm
VF/VT
Survived to
hospital
admission
Survived to
hospital
discharge
CPC
score
1 or 2
Survived to
discharge
(Utstein)
CPC
score
1 or 2
(Utstein)
Japan
(Aichi/
Osaka/
Tokyo)
n=51,381(%)
71.7
(18.4)
29,760
(57.9)
19,176
(40.2)
313
(0.7)
17,221
(33.5)
3,831
(7.5)
n=13,339#
3,644
(27.3)
2,677
(5.2)
1,436
(2.8)
686
(31.2)
463
(21.1)
Korea
(Seoul)
n=7,990(%)
63.5
(19.0)
5,243
(65.6)
2,671
(42.4)
22
(0.3)
3,144
(46.5)
1,233
(15.4)
1,593
(20.4)
712
(8.9)
238
(3.0)
206
(30.8)
122
(18.2)
Malaysia
(Pinang/
Kota Bahru/
Klang Valley)
n=389(%)
57.0
(17.0)
276
(71.0)
84
(22.6)
Not
Available
183
(47.0)
9
(4.1)
31
(8.0)
5
(1.3)
Not
Available
NIL NA
Singapore
n=3,025(%)
63.5
(18.2)
1,988
(65.7)
677
(24.3)
29
(1.1)
1,483
(49.0)
555
(18.7)
514
(17.0)
94
(3.2)
52
(1.7)
37
(11.5)
23
(7.1)
Thailand
(Bangkok/
Songkla)
n=573(%)
55.7
(22.1)
367
(64.0)
83
(15.8)
1
(0.2)
373
(65.1)
19
(7.1)
159
(27.7)
32
(6.8)
10
(1.7)
NIL NA
Taiwan
(Taipei)
n=3,023(%)
70.5
(18.6)
1,936
(64.0)
504
(19.8)
Not
Available
630
(22.1)
296
(9.8)
179
(5.9)
177
(5.9)
91
(3.0)
29
(23.8)
21
(17.2)
UAE
(Dubai)
n=405(%)
49.7
(18.3)
335
(82.7)
41(10.5) 3 (0.8)
186
(45.9)
80
(19.8)
32
(7.9)
13
(3.2)
12
(3.0)
7
(15.2)
7
(15.2)
32. Pan-AsianResuscitationOutcomesStudyPhase2
Out-of-Hospital Cardiac Arrest Presenting to the
EMS Dispatch in the Asia Pacific
Sites
Phase 1 ‘historical’ data (2009-
2011)/minimum 6 months ‘run-
in’ period before implementation
Sites
Phase 1 ‘historical’ data (2009-2011)/minimum 6
months ‘run-in’ period before implementation
Sites Not Implementing Dispatcher-
assisted Cardiopulmonary Resuscitation
Sites Implementing Dispatcher-assisted
Cardiopulmonary Resuscitation
(Intervention)
Phase 1 ‘historical’
data
Collection of Out-of-Hospital Cardiac Arrest and
Dispatcher CPR data
Basic Package Implemention
Dispatcher-CPR
protocol
Training program
Comprehensive Package Implemention
Dispatcher-CPR protocol
Training program
Quality measurement tool
Quality Improvement Program
Community Education Program
Collection of Out-of-
Hospital Cardiac
Arrest data only
33. Survival to hospital discharge for Asia
remains relatively low compared to North
America and some European countries.
This large population-based registry will
provide a baseline to measure the effect of
subsequent interventions such dispatcher-
assisted CPR and PublicAccess Defibrillation
in this region.